Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123069 · ClinicalTrials.gov registry record
Vascular Function and Uterine Fibroids
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 28
- Enrollment target
NCT02123069: Completed study, sponsored by Mayo Clinic.
NCT02123069 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02123069 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how uterine fibroids may be connected to heart disease and high blood pressure. It is not known what causes fibroids, but they frequently occur in women who also have high blood pressure, heart disease, and stroke. The investigators of this study want to learn if certain changes in the blood vessels or nerve activity can put women at risk for these diseases and for fibroids.
Interventions
- DRUG Norepinephrine
- DRUG Acetylcholine
- DRUG Nitroprusside
- DEVICE Brachial artery catheter
- DRUG Nitroprusside and phenylephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-03-01 |
What the finished NCT02123069 record still lists
NCT02123069 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Norepinephrine is the first listed.
NCT02123069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02123069 about?
NCT02123069 is a clinical study titled "Vascular Function and Uterine Fibroids". The purpose of this study is to learn how uterine fibroids may be connected to heart disease and high blood pressure. It is not known what causes fibroids, but they frequently occur in women who also have high blood pressure, heart disease, and stroke. The investigators of this study want to learn i...
What is the current status of trial NCT02123069?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2013-04. Estimated completion is 2018-03-01.
What interventions are being tested in trial NCT02123069?
The interventions under investigation include: Norepinephrine (DRUG), Acetylcholine (DRUG), Nitroprusside (DRUG), Brachial artery catheter (DEVICE), Nitroprusside and phenylephrine (DRUG).
Who is sponsoring clinical trial NCT02123069?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia